How severe is CVE-2020-27269?

CVE-2020-27269 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2020-27269 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-27269?

CVE-2020-27269 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2020-27269?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-27269 published?

CVE-2020-27269 was published on 2021-01-19 and last updated on 2026-06-17.

CVE-2020-27269

CVE-2020-27269 is a medium-severity vulnerability in Sooil Anydana-a Firmware with a CVSS 3.x base score of 5.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-294.

Key facts

Severity: Medium (CVSS 3.x base score 5.7)
CVSS v2: 2.9
EPSS exploit prediction: 0% (39th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-294
Affected product: Sooil Anydana-a Firmware
Published: 2021-01-19
Last modified: 2026-06-17

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.

Frequently asked questions

What is CVE-2020-27269?: In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.
How severe is CVE-2020-27269?: CVE-2020-27269 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-27269 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-27269?: CVE-2020-27269 primarily affects Sooil Anydana-a Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-27269?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-27269 published?: CVE-2020-27269 was published on 2021-01-19 and last updated on 2026-06-17.

References

https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01

Affected products (3)

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*
cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Sooil Anydana-a Firmware

CVE-2020-27264 — High (CVSS 8.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump…
CVE-2020-27256 — Medium (CVSS 6.8): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu…
CVE-2020-27268 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27266 — Medium (CVSS 6.5): In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the…
CVE-2020-27276 — Medium (CVSS 5.7): SOOIL Developments Co Ltd DiabecareRS,AnyDana-i & AnyDana-A, the communication protocol of the insulin pump and its…
CVE-2020-27272 — Medium (CVSS 5.7): SOOIL Developments CoLtd DiabecareRS, AnyDana-i, AnyDana-A, The communication protocol of the insulin pump and…

All CVEs affecting Sooil Anydana-a Firmware →

Other CWE-294 (Authentication Bypass by Capture-replay) vulnerabilities

CVE-2025-49752 — Critical (CVSS 10.0): Azure Bastion Elevation of Privilege Vulnerability
CVE-2026-11856 — Critical (CVSS 9.8): Successfully using libcurl to do a transfer to a specific HTTP origin (`hostA`) with **Digest** authentication and then…
CVE-2026-32987 — Critical (CVSS 9.8): OpenClaw before 2026.3.13 allows bootstrap setup codes to be replayed during device pairing verification in…
CVE-2025-67135 — Critical (CVSS 9.8): Weak Security in the PF-50 1.2 keyfob of PGST PG107 Alarm System 1.25.05.hf allows attackers to compromise access…
CVE-2025-65552 — Critical (CVSS 9.8): D3D Wi-Fi Home Security System ZX-G12 v2.1.1 is vulnerable to RF replay attacks on the 433 MHz sensor communication…
CVE-2024-38438 — Critical (CVSS 9.8): D-Link - CWE-294: Authentication Bypass by Capture-replay

Browse all CWE-294 (Authentication Bypass by Capture-replay) vulnerabilities →